The trial found that the drug amiloride can treat multiple sclerosis
Release date: 2007-12-03 A groundbreaking study has revealed that amiloride, a long-standing medication for high blood pressure, may hold the key to treating multiple sclerosis (MS). Researchers from the University of Oxford recently discovered that this drug could play a critical role in managing the disease, offering new hope for patients worldwide. Multiple sclerosis is an autoimmune disorder where the body's immune system mistakenly attacks its own nerve cells. One of the main factors contributing to the damage is the buildup of excessive calcium within these cells, which leads to the breakdown of the protective myelin sheath surrounding nerves. This process ultimately causes neurological dysfunction and severe disability over time. According to a report published in the journal *Nature Medicine*, amiloride was found to effectively block the accumulation of calcium in nerve cells, thus preventing further damage to the nervous system. This discovery suggests that the drug could be a promising treatment option for MS patients. Lead researcher Lars Fogel emphasized that if further clinical trials confirm the drug’s effectiveness in humans, it could significantly speed up the development of new treatments for MS. Currently, scientists are working on determining the optimal dosage for human use and plan to launch clinical trials in the coming year. This research marks a significant step forward in the fight against multiple sclerosis. With more studies on the way, the medical community remains optimistic about the potential of amiloride as a game-changing therapy for those affected by this debilitating condition. ——Midi Medical Network Centrifuge,Large Capacity Centrifuge,Medical Equipment Centrifuge,Medical Lab Centrifuge Changzhou Timerein Biotechnology Co. , Ltd. , https://www.timereinbiotech.com